SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Evaluation of health technology: Economic issues for health policy and policy issues for economic appraisal
15 references·0 citing·35 second hop
Evaluation of health technology: Economic issues for health policy and policy issues for economic appraisal (1994)Evaluation of health technology: Economic…Methods for the Economic Evaluation of Health Care Programmes (2005)Methods for the Economic Eval…Standardizing Methodologies for Economic Evaluation in Health Care: Practice, Problems, and Potential (1993)Standardizing Methodologies f…Issues in the Cross-National Assessment of Health Technology (1992)Issues in the Cross-National …How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)How attractive does a new tec…Economic Evaluation of Pharmaceuticals (1992)Economic Evaluation of Pharma…Cost‐effectiveness guidelines for reimbursement of pharmaceuticals: Is economic evaluation ready for its enhanced status? (1992)Cost‐effectiveness guidelines…Cost-utility in practice: A policy maker's guide to the state of the art (1992)Cost-utility in practice: A p…Cost-Effectiveness and Cost-Benefit Analyses in the Medical Literature (1992)Cost-Effectiveness and Cost-B…Economic Analysis Alongside Clinical Trials: Revisiting the Methodological Issues (1991)Economic Analysis Alongside C…Economic appraisal of health technology in the european community (1988)Economic appraisal of health …Methods for the economic evaluation of health care programmes (1987)Methods for the economic eval…Prospective reimbursement and the diffusion of new technologies in hospitals (1984)Prospective reimbursement and…Economic analysis and clinical trials (1984)Economic analysis and clinica…The economics of health and medical care (1975)The economics of health and m…Supplier-Induced Demand: Some Empirical Evidence and Implications (1974)Supplier-Induced Demand: Some…Alternative to Mental Hospital Treatment (1980)A methodological framework for assessing health indices (1985)Measurement of health state utilities for economic appraisal (1986)The Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument (1993)A study of the quality of life and cost-utility of renal transplantation (1996)A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial (2012)Alternative to Mental Hospital Treatment (1980)Principles of economic appraisal in health care (1980)Cost-Benefit and Cost-Effectiveness Analysis in Health Care: Principles, Practice and Potential (1983)Quality of life 2 (1993)Statistical analysis of cost outcomes in a randomized controlled clinical trial (1994)Economic Analysis of Respiratory Rehabilitation (1997)Foundations of Cost-Effectiveness Analysis for Health and Medical Practices (1977)A Clinician's Guide to Cost-Effectiveness Analysis (1990)Recommendations for Reporting Cost-effectiveness Analyses (1996)Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1996)The Distinction Between Cost and Charges (1982)Meta-Analysis in Clinical Research (1987)Utility approach to measuring health-related quality of life (1987)Factors that limit the quality, number and progress of randomised controlled trials. (1999)Introducing economic and quality of life measurements into clinical studies (2001)Professional uncertainty and the problem of supplier-induced demand (1982)Physician response to fee changes with multiple payers (1991)Physician Agency (2000)The estimation of a preference-based measure of health from the SF-36 (2002)Systematic reviews: CRD's guidance for undertaking reviews in health care (2010)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)The Estimation of a Preference-Based Measure of Health From the SF-12 (2004)Equity and the economic evaluation of healthcare (2001)Quality of Systematic Reviews of Economic Evaluations in Health Care (2002)Assessing the costs of healthcare technologies in clinical trials. (1999)Variability of Cost-Effectiveness Estimates for Pharmaceuticals in Western Europe: Lessons for Inferring Generalizability (2005)Qaly league tables: Handle with care (1993)Problems With the Interpretation of Pharmacoeconomic Analyses (2000)
this work references cited by second hop

References

  • 2005Methods for the Economic Evaluation of Health Care Programmes13,647 cited
  • 1987Methods for the economic evaluation of health care programmes4,318 cited
  • 1992How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.1,581 cited
  • 1974Supplier-Induced Demand: Some Empirical Evidence and Implications598 cited
  • 1992Cost-Effectiveness and Cost-Benefit Analyses in the Medical Literature410 cited
  • 1991Economic Analysis Alongside Clinical Trials: Revisiting the Methodological Issues337 cited
  • 1993Standardizing Methodologies for Economic Evaluation in Health Care: Practice, Problems, and Potential230 cited
  • 1992Issues in the Cross-National Assessment of Health Technology160 cited
  • 1992Cost-utility in practice: A policy maker's guide to the state of the art141 cited
  • 1984Economic analysis and clinical trials132 cited
  • 1988Economic appraisal of health technology in the european community118 cited
  • 1975The economics of health and medical care115 cited
  • 1984Prospective reimbursement and the diffusion of new technologies in hospitals111 cited
  • 1992Cost‐effectiveness guidelines for reimbursement of pharmaceuticals: Is economic evaluation ready for its enhanced status?86 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 1992Economic Evaluation of Pharmaceuticals55 cited
  • Cited by

    No citing works inside the corpus for this window.